ATE461294T1 - Brustkrebsdiagnoseverfahren - Google Patents

Brustkrebsdiagnoseverfahren

Info

Publication number
ATE461294T1
ATE461294T1 AT06778773T AT06778773T ATE461294T1 AT E461294 T1 ATE461294 T1 AT E461294T1 AT 06778773 T AT06778773 T AT 06778773T AT 06778773 T AT06778773 T AT 06778773T AT E461294 T1 ATE461294 T1 AT E461294T1
Authority
AT
Austria
Prior art keywords
breast cancer
diagnostic procedures
cancer diagnostic
patient
target genes
Prior art date
Application number
AT06778773T
Other languages
English (en)
Inventor
Alexander Krause
Philippe Leissner
Bruno Mougin
Malick Paye
Original Assignee
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Sa filed Critical Biomerieux Sa
Application granted granted Critical
Publication of ATE461294T1 publication Critical patent/ATE461294T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06778773T 2005-07-07 2006-07-05 Brustkrebsdiagnoseverfahren ATE461294T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0552087A FR2888252A1 (fr) 2005-07-07 2005-07-07 Procede pour le diagnostic du cancer du sein
PCT/FR2006/001593 WO2007006911A2 (fr) 2005-07-07 2006-07-05 Procede pour le diagnostic du cancer du sein

Publications (1)

Publication Number Publication Date
ATE461294T1 true ATE461294T1 (de) 2010-04-15

Family

ID=36295403

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778773T ATE461294T1 (de) 2005-07-07 2006-07-05 Brustkrebsdiagnoseverfahren

Country Status (7)

Country Link
US (1) US20090123924A1 (de)
EP (1) EP1917365B1 (de)
CN (1) CN101258250A (de)
AT (1) ATE461294T1 (de)
DE (1) DE602006012995D1 (de)
FR (1) FR2888252A1 (de)
WO (1) WO2007006911A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070280969A1 (en) * 2005-11-23 2007-12-06 The Johns Hopkins University RSF-1 as a prognostic marker and therapeutic target
WO2011039734A2 (en) * 2009-10-02 2011-04-07 Enzo Medico Use of genes involved in anchorage independence for the optimization of diagnosis and treatment of human cancer
WO2011060380A1 (en) * 2009-11-14 2011-05-19 The Regents Of The University Of California Pik3ca mutation status and sash1 expression predicts synergy between lapatinib and an akt inhibitor in her2 positive breast cancer
WO2011147096A1 (en) * 2010-05-28 2011-12-01 Biomerieux Method and kit for discriminating between breast cancer and benign breast disease
CN102680708B (zh) * 2012-05-14 2014-05-21 上海交通大学 诊断试剂盒及rnf19在制备胃癌早期诊断试剂中的应用
CN103602746A (zh) * 2013-11-26 2014-02-26 浙江省肿瘤医院 预测乳腺癌新辅助化疗疗效的生物标记物及其用途
CN103920150B (zh) * 2014-04-17 2016-02-03 北京大学第一医院 Satb1在治疗皮肤t细胞淋巴瘤中的应用
CN111154859A (zh) * 2020-01-17 2020-05-15 中国辐射防护研究院 一种trip12基因突变位点检测试剂盒及其用途
CN111172272A (zh) * 2020-01-17 2020-05-19 中国辐射防护研究院 Trip12基因用作辐射损伤易感性判断的分子标志物的用途
CN113930514A (zh) * 2021-11-22 2022-01-14 上海市东方医院（同济大学附属东方医院） 去泛素化酶usp25在制备诊断乳腺癌的生物标记物中的用途
CN114561411A (zh) * 2022-03-14 2022-05-31 贵州大学 Dicer1基因及其dsRNA在害虫防治中的应用
CN116287277A (zh) * 2023-04-24 2023-06-23 上海生物制品研究所有限责任公司 胞苷脱氨酶活性的生物标记物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
AU2002253878A1 (en) * 2001-01-25 2002-08-06 Gene Logic, Inc. Gene expression profiles in breast tissue
US20030099974A1 (en) * 2001-07-18 2003-05-29 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer
FR2833968A1 (fr) * 2001-12-20 2003-06-27 Ct Medico Chirurgical De Tronq Biopuces thematiques, comportant des modules de recherche associes ou couples, leur procede de preparation, et leurs applications
BRPI0609302A2 (pt) * 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse

Also Published As

Publication number Publication date
FR2888252A1 (fr) 2007-01-12
EP1917365B1 (de) 2010-03-17
CN101258250A (zh) 2008-09-03
WO2007006911A2 (fr) 2007-01-18
EP1917365A2 (de) 2008-05-07
WO2007006911A8 (fr) 2008-05-08
US20090123924A1 (en) 2009-05-14
DE602006012995D1 (de) 2010-04-29
WO2007006911A3 (fr) 2007-08-02

Similar Documents

Publication Publication Date Title
ATE461294T1 (de) Brustkrebsdiagnoseverfahren
NZ601022A (en) Diagnosis and treatment of cancer using anti-ereg antibody
ES2530843T3 (es) Métodos basados en microARN para el diagnóstico de cáncer de páncreas
WO2006127861A3 (en) Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
EP2667194A3 (de) Auf Verhältnis basierende Biomarker und Verfahren zu ihrer Verwendung
EA200802242A1 (ru) Способ определения того, будет или не будет пациент респондером на иммунотерапию
TW200745556A (en) Biomarkers for liver fibrotic injury
CY1114719T1 (el) Ανταγωνιστικα ανθρωπινου light-ειδικα ανθρωπινα μονοκλωνικα αντισωματα
CY1111612T1 (el) Μεθοδος για προβλεψη της αποκρισης σε μια θεραπευτικη αγωγη με εναν αναστολεαδιmερισmου του her
NZ578283A (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
WO2008070666A3 (en) Compositions and methods to treat cancer with cpg rich dna and cupredoxins
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
WO2008155661A3 (en) Methods of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer
WO2009019367A3 (fr) Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
WO2010028373A3 (en) Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
BRPI0815460A2 (pt) kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos
EP1951891A4 (de) Krebsantigen mage-a9 und verwendungen davon
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
WO2009019369A3 (fr) Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal
ATE513929T1 (de) Gene mit einfluss auf die menschliche gedächtnisleistung
WO2007071829A3 (en) Methods and means related to diseases
WO2009019366A3 (fr) Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties